Exercise may improve CIPN symptoms in ovarian cancer patients, though evidence is limited. CIPN is linked to decreased physical function and quality of life, with no consensus on management. Some ...

While there is currently no effective treatment for chemotherapy-induced peripheral neuropathy, one of the most common and severe adverse effects for patients who have undergone chemotherapy for ...

Dr. Stuart Himmelstein, DC, a Philadelphia-based chiropractor, examines how peripheral neuropathy is evaluated in ...

Dr. Jarrod Bagley, D.C., founder of Corrective Health in Austin, spoke with Studio 512 Co-Host Rosie Newberry about a condition called “peripheral neuropathy” and the treatment his office offers. What ...

The Diabetes & Peripheral Neuropathy Research Study needs participants. Requirements include that participants: - Have type 1 or type 2 diabetes. - Have peripheral neuropathy. - Exercise less than ...

Peripheral neuropathy is often characterized by weakness, pain, numbness and tingling in the extremities and debilitating balance problems resulting from nerve damage. This damage is commonly caused ...

In March, I shared a case of a woman with diabetes-related peripheral neuropathy to highlight issues of pain management in primary care. To recap: Maria, age 68, had been experiencing burning pain ...

For more than 100 million Americans who are obese, bariatric surgery may reverse complications related to diabetes, including regenerating damaged nerves, a Michigan Medicine study shows. A research ...

Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...

Dyslipidemia is a known risk factor for diabetic neuropathy, which suggests that lipid-lowering medications might have a preventive effect. In the general population, however, lipid-lowering therapy ...

Please provide your email address to receive an email when new articles are posted on . Women assigned a 6-month intervention reported decreased chemotherapy-induced peripheral neuropathy symptoms.